Although the precise mechanisms of U2AF1 mutants in the pathogenesis of MDS and AML remain largely unclear, a growing number of studies are dedicated to explaining the biological impacts and carcinogenic effects of U2AF1 mutations. The gene discussed is U2AF1; the disease is acute myeloid leukemia.